Journal
Spotlights
Webinars
Channels
Analytics
Manufacturing
Vectors
Regulatory
Supply Chain
Translational Research & Clinical Development
Business and Finance
Reports
Regulatory Insights
Clinical Trends
Innovation Insights
Business Insights
Investor Insights
FastFacts
Media Kit
Media Kit
Editorial calendar
Sponsorship opportunities
Webinars
About
Submit your manuscript
Meet the team
Get in touch
Immuno-Oncology Insights
Login
Register
Update your profile
Logout
CELL & GENE THERAPY
INSIGHTS
Cellular immuno-oncology – overcoming manufacturing and development obstacles to commercial success
Guest Editor:
Fritz Fiesser, Director, C> Engineering and Informatics at GlaxoSmithKline
Fritz Fiesser
Director, C> Engineering and Informatics at GlaxoSmithKline
June 2021
Sponsor
Download full spotlight
Navigating regulations: novel cell therapy platforms and their path to clinical manufacturing
N Bauer,
N Calhoun,
A Davies
et al.
11 August 2021
Innovator Insight
Read more
Accelerating CAR-T process development: The power of process insight
Julia Hupfeld, Ph.D., Advanced Therapies Expert, Sartorius
29 July 2021
Webinar
Watch now
Allogeneic T-cell therapies: from R&D lab to production facility
J Dupont,
J Newell
9 June 2021
Viewpoint
Read more
Towards the rational design of a next-generation dendritic cell vaccine for cancer immunotherapy
M Bravo,
T Davies,
P Fairchild
8 June 2021
Commentary
Read more
Pursuing a fully closed cellular immunotherapy manufacturing model
E Samuel
8 June 2021
Interview
Read more
Optimizing manufacturing processes to develop novel cell and gene therapies
K Ingalls
7 June 2021
Interview
Read more
Reflecting upon the GSK–UCL collaboration on viral vector bioprocess economics for
ex vivo
gene therapy commercialization
S Farid
25 May 2021
Interview
Read more
Applying a closed, modular, semi-automated system to CAR T cell therapy manufacturing
Yongchang Ji, Manager of Product Applications, Cell and Gene Therapy, Thermo Fisher Scientific
Semsi Ensari, PhD, Senior Director, Kite Pharma
Nathan Moore, PhD, Associate Director, Engineering & Automation Cell Therapies, Pharmaceutical Sciences, Takeda
29 June 2021
Webinar
Watch now
A bright commercial future for off-the-shelf NK cell therapy
J Spanholtz,
T Jordansen,
V Huppert
11 May 2021
Interview
Read more
CMC obstacles in cell and gene therapy: four solutions to solve six challenges
S Viswanathan,
M Puich
10 May 2021
Innovator Insight
Read more
Navigating regulations - novel cell therapy platforms and their path to clinical manufacturing
Nina Bauer, Head of Commercial, Gene Editing and Novel Modalities, Merck KGaA
Natika Calhoun, Regulatory Consultant, Merck KGaA
Anthony Davies, Founder and CEO, Dark Horse Consulting
Matt Muldoon, Senior Director, Supplier Management, Allogene Therapeutics
27 May 2021
Webinar
Watch now
×
Please enter your email to register
Register